FWIA
REGN icon

Fort Washington Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Fort Washington Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-712
Closed -$246K – 560
2018
Q2 		$246K Sell
712
-2,721
-79% -$851K ﹤0.01% 509
2018
Q1 		$1.18M Sell
3,433
-445
-11% -$155K 0.01% 352
2017
Q4 		$1.46M Buy
3,878
+35
+0.9% +$14.2K 0.01% 363
2017
Q3 		$1.72M Sell
3,843
-145
-4% -$69K 0.03% 246
2017
Q2 		$1.96M Sell
3,988
-20
-0.5% -$8.75K 0.03% 226
2017
Q1 		$1.55M Sell
4,008
-285
-7% -$106K 0.02% 262
2016
Q4 		$1.58M Sell
4,293
-305
-7% -$116K 0.03% 262
2016
Q3 		$1.85M Sell
4,598
-20
-0.4% -$8.02K 0.03% 210
2016
Q2 		$1.61M Sell
4,618
-1,297
-22% -$500K 0.03% 229
2016
Q1 		$2.13M Buy
+5,915
New +$2.44M 0.04% 201
2015
Q4 		– Sell
-7,335
Closed -$3.41M – 426
2015
Q3 		$3.41M Sell
7,335
-275
-4% -$148K 0.07% 162
2015
Q2 		$3.88M Buy
7,610
+700
+10% +$342K 0.07% 150
2015
Q1 		$3.12M Sell
6,910
-250
-3% -$106K 0.06% 167
2014
Q4 		$2.94M Sell
7,160
-50
-0.7% -$19.7K 0.06% 172
2014
Q3 		$2.6M Sell
7,210
-230
-3% -$77.1K 0.05% 190
2014
Q2 		$2.1M Sell
7,440
-1,125
-13% -$333K 0.04% 226
2014
Q1 		$2.57M Sell
8,565
-1,300
-13% -$401K 0.06% 185
2013
Q4 		$2.71M Buy
9,865
+2,025
+26% +$582K 0.06% 215
2013
Q3 		$2.45M Buy
7,840
+5,740
+273% +$1.51M 0.06% 242
2013
Q2 		$472K Buy
+2,100
New +$489K 0.01% 355

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fort Washington Investment Advisors's REGN Position: Q3 2018 in Review

Fort Washington Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2018, closing a stake of 712 shares — an estimated $246K sold.

Fort Washington Investment Advisors first reported a position in REGN in Q2 2013 and held it in 20 quarters. The position peaked at $3.88M in Q2 2015. 645 funds tracked by Wall St. Rank hold REGN as of Q3 2018.

  • Fort Washington Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 712 Regeneron Pharmaceuticals shares in Q3 2018, an estimated $246K.
  • Fort Washington Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Fort Washington Investment Advisors's Regeneron Pharmaceuticals position peaked at $3.88M in Q2 2015.
  • 645 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2018.

Based on Fort Washington Investment Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.